mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.22 |
6e-09 |
mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.21 |
1e-08 |
mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.21 |
2e-08 |
mRNA |
AZD6244 |
CTRPv2 |
pan-cancer |
AAC |
-0.21 |
2e-08 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.2 |
6e-08 |
mRNA |
etoposide |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
2e-07 |
mRNA |
PD318088 |
CTRPv2 |
pan-cancer |
AAC |
-0.19 |
2e-07 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
1e-06 |
mRNA |
RDEA119 |
GDSC1000 |
pan-cancer |
AAC |
-0.14 |
2e-06 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
2e-06 |